T1	Participants 646 786	Between 1999 and 2002, 1397 antiretroviral-treatment-naive patients, presenting at 18 clinical trial units with 80 research sites in the USA
T2	Participants 1479 1533	1397 patients were assessed for the composite endpoint
T3	Participants 3011 3044	treatment-naive patients with HIV
